Supplemental material
Open access
3,339
Views
1
CrossRef citations to date
0
Altmetric
Report
Design of antibody variable fragments with reduced reactivity to preexisting anti-drug antibodies
Maria U. JohanssonNumab Therapeutics AG, Horgen, SwitzerlandView further author information
, Christopher WeinertNumab Therapeutics AG, Horgen, SwitzerlandView further author information
, Dietrich Alexander ReichardtNumab Therapeutics AG, Horgen, SwitzerlandView further author information
, Dana MahlerNumab Therapeutics AG, Horgen, SwitzerlandView further author information
, Dania DiemNumab Therapeutics AG, Horgen, SwitzerlandView further author information
, Christian HessNumab Therapeutics AG, Horgen, SwitzerlandView further author information
, Diana FeusiNumab Therapeutics AG, Horgen, SwitzerlandView further author information
, Simon CarnalNumab Therapeutics AG, Horgen, SwitzerlandView further author information
, Julia TietzNumab Therapeutics AG, Horgen, SwitzerlandView further author information
, Noreen GiezendannerNumab Therapeutics AG, Horgen, SwitzerlandView further author information
, Fabio Mario SpigaNumab Therapeutics AG, Horgen, SwitzerlandView further author information
, David UrechNumab Therapeutics AG, Horgen, SwitzerlandView further author information
& Stefan WarmuthNumab Therapeutics AG, Horgen, SwitzerlandCorrespondence[email protected]
https://orcid.org/0000-0001-6872-8805View further author information
show allhttps://orcid.org/0000-0001-6872-8805View further author information
Article: 2215887
|
Received 30 Dec 2022, Accepted 03 May 2023, Published online: 13 Jun 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.